Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by symbiont of host defense response (GO:0052031) | 5.52393302 |
2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.52393302 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.52393302 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.52393302 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.52393302 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.52393302 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42338026 |
8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44020693 |
9 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.41502244 |
10 | activated T cell proliferation (GO:0050798) | 4.39165209 |
11 | negative regulation of T cell mediated immunity (GO:0002710) | 4.32149920 |
12 | negative regulation of cell killing (GO:0031342) | 4.30008768 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30008768 |
14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28804233 |
15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.28804233 |
16 | detection of other organism (GO:0098543) | 4.22026905 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.17364824 |
18 | neutrophil activation involved in immune response (GO:0002283) | 4.15784454 |
19 | detection of bacterium (GO:0016045) | 4.11129063 |
20 | T cell migration (GO:0072678) | 4.01175307 |
21 | tolerance induction (GO:0002507) | 3.94975335 |
22 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.91512855 |
23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.89391020 |
24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.88692319 |
25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.83858069 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80647436 |
27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.79172548 |
28 | B cell receptor signaling pathway (GO:0050853) | 3.72296546 |
29 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.70602866 |
30 | respiratory burst (GO:0045730) | 3.66451944 |
31 | macrophage activation involved in immune response (GO:0002281) | 3.61333428 |
32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.57663857 |
33 | response to host immune response (GO:0052572) | 3.57663857 |
34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57649203 |
35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.54902166 |
36 | negative T cell selection (GO:0043383) | 3.54876286 |
37 | positive regulation of granulocyte differentiation (GO:0030854) | 3.52658098 |
38 | negative thymic T cell selection (GO:0045060) | 3.50048110 |
39 | regulation of T cell tolerance induction (GO:0002664) | 3.49703701 |
40 | immunoglobulin mediated immune response (GO:0016064) | 3.48228936 |
41 | response to peptidoglycan (GO:0032494) | 3.48224670 |
42 | detection of external biotic stimulus (GO:0098581) | 3.48042316 |
43 | positive regulation of interleukin-17 production (GO:0032740) | 3.46988565 |
44 | response to muramyl dipeptide (GO:0032495) | 3.43389084 |
45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.42864325 |
46 | positive thymic T cell selection (GO:0045059) | 3.42702017 |
47 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.34519451 |
48 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.34519451 |
49 | * leukocyte aggregation (GO:0070486) | 3.33317373 |
50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32565961 |
51 | myeloid cell activation involved in immune response (GO:0002275) | 3.31844261 |
52 | regulation of interferon-alpha production (GO:0032647) | 3.31592095 |
53 | neutrophil activation (GO:0042119) | 3.29227875 |
54 | regulation of tolerance induction (GO:0002643) | 3.28562214 |
55 | positive regulation of B cell differentiation (GO:0045579) | 3.28420583 |
56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28404828 |
57 | response to host (GO:0075136) | 3.28404828 |
58 | response to host defenses (GO:0052200) | 3.28404828 |
59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27956586 |
60 | positive regulation of interferon-alpha production (GO:0032727) | 3.26097637 |
61 | mast cell activation (GO:0045576) | 3.24711425 |
62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22388321 |
63 | regulation of B cell differentiation (GO:0045577) | 3.22107873 |
64 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.21831988 |
65 | granulocyte activation (GO:0036230) | 3.20696481 |
66 | regulation of regulatory T cell differentiation (GO:0045589) | 3.20024545 |
67 | detection of molecule of bacterial origin (GO:0032490) | 3.18263431 |
68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.17712210 |
69 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.16910682 |
70 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.16910682 |
71 | response to interleukin-15 (GO:0070672) | 3.16871301 |
72 | negative regulation of interleukin-12 production (GO:0032695) | 3.15289129 |
73 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06955367 |
74 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.06701477 |
75 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04832094 |
76 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.04708593 |
77 | detection of biotic stimulus (GO:0009595) | 3.03790377 |
78 | B cell homeostasis (GO:0001782) | 3.03719794 |
79 | positive regulation of interleukin-2 production (GO:0032743) | 3.02633787 |
80 | interferon-gamma production (GO:0032609) | 3.02456320 |
81 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.00746524 |
82 | cellular response to interleukin-15 (GO:0071350) | 3.00679936 |
83 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.00359186 |
84 | microglial cell activation (GO:0001774) | 3.00120986 |
85 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99660185 |
86 | macrophage activation (GO:0042116) | 2.98969979 |
87 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.98640987 |
88 | negative regulation of adaptive immune response (GO:0002820) | 2.98244328 |
89 | neutrophil mediated immunity (GO:0002446) | 2.97329983 |
90 | defense response to protozoan (GO:0042832) | 2.95874333 |
91 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95675974 |
92 | regulation of interleukin-17 production (GO:0032660) | 2.94302094 |
93 | positive regulation of tolerance induction (GO:0002645) | 2.94147074 |
94 | positive T cell selection (GO:0043368) | 2.92374874 |
95 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.91893792 |
96 | cellular extravasation (GO:0045123) | 2.90896671 |
97 | germinal center formation (GO:0002467) | 2.90852149 |
98 | thymic T cell selection (GO:0045061) | 2.89812820 |
99 | regulation of antigen processing and presentation (GO:0002577) | 2.89584713 |
100 | regulation of mast cell degranulation (GO:0043304) | 2.87985379 |
101 | T cell receptor signaling pathway (GO:0050852) | 2.87910093 |
102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87525908 |
103 | negative regulation of B cell proliferation (GO:0030889) | 2.86396193 |
104 | regulation of chronic inflammatory response (GO:0002676) | 2.86174254 |
105 | T cell selection (GO:0045058) | 2.85676889 |
106 | NIK/NF-kappaB signaling (GO:0038061) | 2.85248249 |
107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.85202731 |
108 | * leukocyte cell-cell adhesion (GO:0007159) | 2.84995476 |
109 | modulation by symbiont of host cellular process (GO:0044068) | 2.84096271 |
110 | T cell proliferation (GO:0042098) | 2.83206702 |
111 | myeloid dendritic cell activation (GO:0001773) | 2.82347368 |
112 | T cell costimulation (GO:0031295) | 2.82316486 |
113 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82172854 |
114 | positive regulation of mast cell activation (GO:0033005) | 2.79655048 |
115 | myeloid dendritic cell differentiation (GO:0043011) | 2.79528590 |
116 | type I interferon signaling pathway (GO:0060337) | 2.78429257 |
117 | cellular response to type I interferon (GO:0071357) | 2.78429257 |
118 | response to type I interferon (GO:0034340) | 2.78241970 |
119 | heterotypic cell-cell adhesion (GO:0034113) | 2.78148297 |
120 | lymphocyte costimulation (GO:0031294) | 2.77583886 |
121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.77177104 |
122 | leukocyte degranulation (GO:0043299) | 2.77121569 |
123 | response to lipoprotein particle (GO:0055094) | 2.76932112 |
124 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76816295 |
125 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.76717293 |
126 | response to protozoan (GO:0001562) | 2.76537531 |
127 | Rap protein signal transduction (GO:0032486) | 2.74035770 |
128 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.72661049 |
129 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71781259 |
130 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71422643 |
131 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.71415348 |
132 | T cell homeostasis (GO:0043029) | 2.69743484 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.00223035 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.44300000 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.04540170 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.54544109 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.25306397 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.86576338 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.79550069 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.74239674 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66309808 |
10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.33015407 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28943980 |
12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.19700690 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03792368 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.99757335 |
15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.94401839 |
16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.93531321 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.93442335 |
18 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.70529311 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62190172 |
20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.55452282 |
21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.51223579 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46460012 |
23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.35526215 |
24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.35014944 |
25 | MYC_22102868_ChIP-Seq_BL_Human | 2.34163112 |
26 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31612032 |
27 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.25875993 |
28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.24130241 |
29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13753133 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08812654 |
31 | MYB_26560356_Chip-Seq_TH1_Human | 2.08664501 |
32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06717995 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06294181 |
34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97253923 |
35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93999255 |
36 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.92998798 |
37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90052635 |
38 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.89978423 |
39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81019132 |
40 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76882001 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69152453 |
42 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.62258629 |
43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60052534 |
44 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.54562133 |
45 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.54074600 |
46 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52000804 |
47 | MAF_26560356_Chip-Seq_TH2_Human | 1.49631835 |
48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47472886 |
49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43633662 |
50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41031532 |
51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40040192 |
52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38477369 |
53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34951422 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31777810 |
55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28788535 |
56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28482810 |
57 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.27317128 |
58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24476089 |
59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23005914 |
60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17642219 |
61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.17420481 |
62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17179482 |
63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16894475 |
64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14486967 |
65 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13526628 |
66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12439324 |
67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11302271 |
68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10455846 |
69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10030609 |
70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09981608 |
71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07453522 |
72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07446815 |
73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07420160 |
74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07030220 |
75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06611306 |
76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05142722 |
77 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04679445 |
78 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03016568 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00540847 |
80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00092245 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98833963 |
82 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97830561 |
83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95820712 |
84 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95279026 |
85 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95052885 |
86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93816883 |
87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93089466 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90271436 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90167141 |
90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87646443 |
91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86914825 |
92 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86596021 |
93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86233154 |
94 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.84725235 |
95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83921216 |
96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82438090 |
97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80455974 |
98 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.76018801 |
99 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74081847 |
100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72753442 |
101 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67641572 |
102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66244137 |
103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65956905 |
104 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.62835697 |
105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58831932 |
106 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.58609133 |
107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.58275316 |
108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.57878744 |
109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57628072 |
110 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56639184 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.92376988 |
2 | MP0005671_abnormal_response_to | 3.41888627 |
3 | MP0005387_immune_system_phenotype | 3.39002718 |
4 | MP0001790_abnormal_immune_system | 3.39002718 |
5 | MP0003303_peritoneal_inflammation | 3.28135203 |
6 | MP0006082_CNS_inflammation | 3.24867921 |
7 | MP0005000_abnormal_immune_tolerance | 3.22557396 |
8 | * MP0001800_abnormal_humoral_immune | 3.15061989 |
9 | MP0009785_altered_susceptibility_to | 2.98954580 |
10 | MP0000685_abnormal_immune_system | 2.97422168 |
11 | * MP0002452_abnormal_antigen_presenting | 2.86875533 |
12 | MP0003436_decreased_susceptibility_to | 2.85839933 |
13 | * MP0002723_abnormal_immune_serum | 2.81326769 |
14 | MP0002419_abnormal_innate_immunity | 2.81084755 |
15 | MP0005058_abnormal_lysosome_morphology | 2.80758393 |
16 | MP0005025_abnormal_response_to | 2.72631732 |
17 | * MP0002420_abnormal_adaptive_immunity | 2.63940517 |
18 | MP0004510_myositis | 2.63607876 |
19 | * MP0001819_abnormal_immune_cell | 2.61998846 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.55270657 |
21 | MP0003172_abnormal_lysosome_physiology | 2.51639402 |
22 | MP0003763_abnormal_thymus_physiology | 2.46205588 |
23 | MP0003300_gastrointestinal_ulcer | 2.36121952 |
24 | MP0005310_abnormal_salivary_gland | 2.21490113 |
25 | MP0004947_skin_inflammation | 2.20384228 |
26 | * MP0002398_abnormal_bone_marrow | 2.19837396 |
27 | MP0000920_abnormal_myelination | 2.13577152 |
28 | MP0009333_abnormal_splenocyte_physiolog | 2.11663601 |
29 | * MP0000716_abnormal_immune_system | 2.11505112 |
30 | MP0002405_respiratory_system_inflammati | 2.10467622 |
31 | MP0005464_abnormal_platelet_physiology | 2.06704119 |
32 | MP0003690_abnormal_glial_cell | 1.92651314 |
33 | MP0009278_abnormal_bone_marrow | 1.86074020 |
34 | * MP0000689_abnormal_spleen_morphology | 1.84319010 |
35 | MP0003724_increased_susceptibility_to | 1.78760613 |
36 | MP0002722_abnormal_immune_system | 1.75801749 |
37 | MP0001845_abnormal_inflammatory_respons | 1.73734556 |
38 | MP0010155_abnormal_intestine_physiology | 1.73501489 |
39 | * MP0002429_abnormal_blood_cell | 1.67118769 |
40 | MP0001533_abnormal_skeleton_physiology | 1.56592321 |
41 | MP0002933_joint_inflammation | 1.56474810 |
42 | MP0001873_stomach_inflammation | 1.51272590 |
43 | MP0000604_amyloidosis | 1.50925043 |
44 | MP0000703_abnormal_thymus_morphology | 1.48262636 |
45 | MP0001851_eye_inflammation | 1.47212332 |
46 | MP0002396_abnormal_hematopoietic_system | 1.44417462 |
47 | MP0003448_altered_tumor_morphology | 1.42844255 |
48 | MP0003866_abnormal_defecation | 1.42130066 |
49 | MP0001853_heart_inflammation | 1.39078119 |
50 | MP0002132_abnormal_respiratory_system | 1.38262913 |
51 | MP0000465_gastrointestinal_hemorrhage | 1.37721730 |
52 | MP0002166_altered_tumor_susceptibility | 1.32927093 |
53 | MP0003183_abnormal_peptide_metabolism | 1.32726574 |
54 | MP0000569_abnormal_digit_pigmentation | 1.26716511 |
55 | MP0008469_abnormal_protein_level | 1.24233914 |
56 | MP0005174_abnormal_tail_pigmentation | 1.23187176 |
57 | MP0002998_abnormal_bone_remodeling | 1.18513351 |
58 | MP0002006_tumorigenesis | 1.16840043 |
59 | MP0004883_abnormal_blood_vessel | 1.11686781 |
60 | MP0000343_altered_response_to | 1.10097635 |
61 | MP0001545_abnormal_hematopoietic_system | 1.02099158 |
62 | MP0005397_hematopoietic_system_phenotyp | 1.02099158 |
63 | MP0000015_abnormal_ear_pigmentation | 1.00455976 |
64 | MP0009764_decreased_sensitivity_to | 0.99537596 |
65 | MP0004808_abnormal_hematopoietic_stem | 0.95327316 |
66 | MP0002009_preneoplasia | 0.94465842 |
67 | MP0003075_altered_response_to | 0.94143750 |
68 | MP0004130_abnormal_muscle_cell | 0.93300892 |
69 | MP0000858_altered_metastatic_potential | 0.88611798 |
70 | MP0003634_abnormal_glial_cell | 0.86928474 |
71 | MP0001986_abnormal_taste_sensitivity | 0.86447098 |
72 | MP0000383_abnormal_hair_follicle | 0.84874911 |
73 | MP0003453_abnormal_keratinocyte_physiol | 0.80466618 |
74 | MP0002138_abnormal_hepatobiliary_system | 0.77809740 |
75 | MP0010307_abnormal_tumor_latency | 0.75332969 |
76 | MP0005166_decreased_susceptibility_to | 0.74289164 |
77 | MP0003045_fibrosis | 0.74102973 |
78 | MP0003329_amyloid_beta_deposits | 0.73255470 |
79 | MP0008004_abnormal_stomach_pH | 0.72428011 |
80 | MP0008874_decreased_physiological_sensi | 0.71000510 |
81 | MP0003191_abnormal_cellular_cholesterol | 0.70771209 |
82 | MP0004742_abnormal_vestibular_system | 0.70573297 |
83 | MP0008057_abnormal_DNA_replication | 0.70439423 |
84 | MP0004381_abnormal_hair_follicle | 0.69283613 |
85 | MP0000490_abnormal_crypts_of | 0.67938719 |
86 | MP0005075_abnormal_melanosome_morpholog | 0.66766931 |
87 | MP0009840_abnormal_foam_cell | 0.66545074 |
88 | MP0008569_lethality_at_weaning | 0.63836404 |
89 | MP0005451_abnormal_body_composition | 0.62366200 |
90 | MP0009763_increased_sensitivity_to | 0.61332721 |
91 | MP0004185_abnormal_adipocyte_glucose | 0.60803156 |
92 | MP0003656_abnormal_erythrocyte_physiolo | 0.60135059 |
93 | MP0008260_abnormal_autophagy | 0.59550779 |
94 | MP0003795_abnormal_bone_structure | 0.59163887 |
95 | MP0003787_abnormal_imprinting | 0.58777162 |
96 | MP0005164_abnormal_response_to | 0.57408684 |
97 | MP0009765_abnormal_xenobiotic_induced | 0.56338973 |
98 | MP0005390_skeleton_phenotype | 0.56184605 |
99 | MP0002693_abnormal_pancreas_physiology | 0.56015586 |
100 | MP0003091_abnormal_cell_migration | 0.55556462 |
101 | MP0001348_abnormal_lacrimal_gland | 0.55357286 |
102 | MP0002277_abnormal_respiratory_mucosa | 0.55277490 |
103 | MP0005076_abnormal_cell_differentiation | 0.54680438 |
104 | MP0003566_abnormal_cell_adhesion | 0.52701305 |
105 | MP0001663_abnormal_digestive_system | 0.52432796 |
106 | MP0002332_abnormal_exercise_endurance | 0.52113995 |
107 | MP0008961_abnormal_basal_metabolism | 0.51566706 |
108 | MP0000249_abnormal_blood_vessel | 0.50944013 |
109 | MP0002019_abnormal_tumor_incidence | 0.50687695 |
110 | MP0010678_abnormal_skin_adnexa | 0.49535941 |
111 | MP0005535_abnormal_body_temperature | 0.49513026 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.49045929 |
113 | MP0008873_increased_physiological_sensi | 0.48651404 |
114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46554968 |
115 | MP0004484_altered_response_of | 0.46390383 |
116 | MP0003632_abnormal_nervous_system | 0.46364151 |
117 | MP0003828_pulmonary_edema | 0.43183747 |
118 | MP0000371_diluted_coat_color | 0.42598020 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.78078530 |
2 | Stomatitis (HP:0010280) | 5.16719530 |
3 | Eczematoid dermatitis (HP:0000976) | 4.95210370 |
4 | Recurrent bacterial skin infections (HP:0005406) | 4.89090978 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.70538261 |
6 | Increased cerebral lipofuscin (HP:0011813) | 4.45127059 |
7 | Abnormality of macrophages (HP:0004311) | 4.28444620 |
8 | Myositis (HP:0100614) | 4.15776625 |
9 | Chronic otitis media (HP:0000389) | 4.12944420 |
10 | Recurrent fungal infections (HP:0002841) | 4.10216358 |
11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.08967813 |
12 | Recurrent viral infections (HP:0004429) | 4.06359455 |
13 | Gastrointestinal infarctions (HP:0005244) | 3.92154283 |
14 | Optic neuritis (HP:0100653) | 3.91685254 |
15 | Retrobulbar optic neuritis (HP:0100654) | 3.91685254 |
16 | T lymphocytopenia (HP:0005403) | 3.86801249 |
17 | Abnormality of T cell number (HP:0011839) | 3.78046742 |
18 | Recurrent skin infections (HP:0001581) | 3.78002008 |
19 | Obstructive lung disease (HP:0006536) | 3.71909273 |
20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.71909273 |
21 | Mediastinal lymphadenopathy (HP:0100721) | 3.66928144 |
22 | Prolonged bleeding time (HP:0003010) | 3.66402890 |
23 | Vasculitis (HP:0002633) | 3.62603686 |
24 | Orchitis (HP:0100796) | 3.57138903 |
25 | Gastrointestinal stroma tumor (HP:0100723) | 3.31203479 |
26 | Meningitis (HP:0001287) | 3.26289622 |
27 | IgM deficiency (HP:0002850) | 3.26121668 |
28 | Vacuolated lymphocytes (HP:0001922) | 3.25330483 |
29 | Chest pain (HP:0100749) | 3.24957936 |
30 | Cellulitis (HP:0100658) | 3.23074877 |
31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.22003513 |
32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.22003513 |
33 | Recurrent bronchitis (HP:0002837) | 3.19849277 |
34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.18936494 |
35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.18936494 |
36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.18936494 |
37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.09673173 |
38 | Panhypogammaglobulinemia (HP:0003139) | 3.09598686 |
39 | Leukocytosis (HP:0001974) | 3.03624620 |
40 | Inflammation of the large intestine (HP:0002037) | 2.97786090 |
41 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.96248162 |
42 | Autoimmune thrombocytopenia (HP:0001973) | 2.91546249 |
43 | Eosinophilia (HP:0001880) | 2.90848985 |
44 | Hypochromic anemia (HP:0001931) | 2.89870221 |
45 | Epistaxis (HP:0000421) | 2.89292717 |
46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.88654097 |
47 | Dysostosis multiplex (HP:0000943) | 2.88089396 |
48 | Autoimmune hemolytic anemia (HP:0001890) | 2.86033578 |
49 | Loss of speech (HP:0002371) | 2.85969990 |
50 | Gastrointestinal inflammation (HP:0004386) | 2.83123846 |
51 | Abnormality of T cells (HP:0002843) | 2.80792257 |
52 | Thyroiditis (HP:0100646) | 2.80699578 |
53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.76892473 |
54 | Gingival bleeding (HP:0000225) | 2.76160711 |
55 | Papilledema (HP:0001085) | 2.75645072 |
56 | Hepatosplenomegaly (HP:0001433) | 2.74364933 |
57 | Gingivitis (HP:0000230) | 2.73605954 |
58 | Colitis (HP:0002583) | 2.72747424 |
59 | Lymphopenia (HP:0001888) | 2.72706169 |
60 | Hypochromic microcytic anemia (HP:0004840) | 2.72025015 |
61 | Pustule (HP:0200039) | 2.69792160 |
62 | Pulmonary infiltrates (HP:0002113) | 2.67523761 |
63 | Abnormality of eosinophils (HP:0001879) | 2.67026019 |
64 | Arterial thrombosis (HP:0004420) | 2.66445962 |
65 | Agammaglobulinemia (HP:0004432) | 2.65133358 |
66 | Nasal polyposis (HP:0100582) | 2.61792645 |
67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.61031271 |
68 | Abnormality of the fingertips (HP:0001211) | 2.58975245 |
69 | Pulmonary embolism (HP:0002204) | 2.57904060 |
70 | Severe combined immunodeficiency (HP:0004430) | 2.57288995 |
71 | Parakeratosis (HP:0001036) | 2.47753137 |
72 | Interstitial pulmonary disease (HP:0006530) | 2.46488200 |
73 | Slow saccadic eye movements (HP:0000514) | 2.43763366 |
74 | Thick nail (HP:0001805) | 2.42620479 |
75 | Verrucae (HP:0200043) | 2.42007966 |
76 | Papilloma (HP:0012740) | 2.42007966 |
77 | Recurrent pneumonia (HP:0006532) | 2.41148546 |
78 | Combined immunodeficiency (HP:0005387) | 2.40171803 |
79 | Emphysema (HP:0002097) | 2.38905906 |
80 | Small epiphyses (HP:0010585) | 2.38655559 |
81 | Increased IgM level (HP:0003496) | 2.38270903 |
82 | Anorexia (HP:0002039) | 2.37655056 |
83 | Episodic fever (HP:0001954) | 2.36557865 |
84 | Restrictive lung disease (HP:0002091) | 2.35705730 |
85 | IgA deficiency (HP:0002720) | 2.34345214 |
86 | IgG deficiency (HP:0004315) | 2.34285963 |
87 | Granulocytopenia (HP:0001913) | 2.33358074 |
88 | Disinhibition (HP:0000734) | 2.31376886 |
89 | Encephalitis (HP:0002383) | 2.30088065 |
90 | Keratoconjunctivitis sicca (HP:0001097) | 2.27357843 |
91 | Abnormality of B cell number (HP:0010975) | 2.26324003 |
92 | B lymphocytopenia (HP:0010976) | 2.26324003 |
93 | Sepsis (HP:0100806) | 2.25183248 |
94 | Osteomyelitis (HP:0002754) | 2.24829263 |
95 | Spontaneous hematomas (HP:0007420) | 2.23287507 |
96 | Hemoptysis (HP:0002105) | 2.17942516 |
97 | Microcytic anemia (HP:0001935) | 2.17443706 |
98 | Axonal loss (HP:0003447) | 2.15614549 |
99 | Hypergammaglobulinemia (HP:0010702) | 2.15595542 |
100 | Urticaria (HP:0001025) | 2.14252582 |
101 | Chronic diarrhea (HP:0002028) | 2.11141259 |
102 | Gangrene (HP:0100758) | 2.10201295 |
103 | Abnormality of the pleura (HP:0002103) | 2.09910080 |
104 | Abnormality of the nasal mucosa (HP:0000433) | 2.09906692 |
105 | Abnormal platelet volume (HP:0011876) | 2.09629484 |
106 | Petechiae (HP:0000967) | 2.09587560 |
107 | Hemiplegia (HP:0002301) | 2.08596455 |
108 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06214180 |
109 | Keratoconjunctivitis (HP:0001096) | 2.05957733 |
110 | Abnormality of T cell physiology (HP:0011840) | 2.05575027 |
111 | Neurofibrillary tangles (HP:0002185) | 2.05569388 |
112 | Acute hepatic failure (HP:0006554) | 2.05557408 |
113 | Increased IgE level (HP:0003212) | 2.05044780 |
114 | Supranuclear gaze palsy (HP:0000605) | 2.04900513 |
115 | Basal ganglia calcification (HP:0002135) | 2.04799106 |
116 | Mucopolysacchariduria (HP:0008155) | 2.04530513 |
117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04530513 |
118 | Viral hepatitis (HP:0006562) | 2.03348250 |
119 | Recurrent sinusitis (HP:0011108) | 2.03142760 |
120 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00498984 |
121 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00498984 |
122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99890531 |
123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99890531 |
124 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99890531 |
125 | Chronic sinusitis (HP:0011109) | 1.99278062 |
126 | Joint swelling (HP:0001386) | 1.97448668 |
127 | Purpura (HP:0000979) | 1.96568294 |
128 | Diplopia (HP:0000651) | 1.95963780 |
129 | Abnormality of binocular vision (HP:0011514) | 1.95963780 |
130 | Abnormality of the endocardium (HP:0004306) | 1.95796727 |
131 | Skin ulcer (HP:0200042) | 1.94637153 |
132 | Lymphoma (HP:0002665) | 1.92153116 |
133 | Vertigo (HP:0002321) | 1.91824921 |
134 | Stomach cancer (HP:0012126) | 1.84946067 |
135 | Glomerulopathy (HP:0100820) | 1.80839712 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.86958160 |
2 | TXK | 3.73626123 |
3 | EPHB1 | 3.42946290 |
4 | IRAK4 | 2.89965994 |
5 | TBK1 | 2.62855877 |
6 | TYK2 | 2.58524448 |
7 | MAP3K14 | 2.45366817 |
8 | IKBKE | 2.41870409 |
9 | JAK3 | 2.28659393 |
10 | KIT | 2.21001399 |
11 | BLK | 2.11960453 |
12 | STK10 | 2.11639185 |
13 | ITK | 2.07812575 |
14 | FES | 2.07542002 |
15 | RIPK4 | 2.04809417 |
16 | CSK | 1.97861814 |
17 | IRAK3 | 1.95818561 |
18 | ZAP70 | 1.93103147 |
19 | CSF1R | 1.90366280 |
20 | IKBKB | 1.86669375 |
21 | CLK1 | 1.84441389 |
22 | JAK1 | 1.82365702 |
23 | STK39 | 1.77630901 |
24 | SYK | 1.71023046 |
25 | FGR | 1.64617178 |
26 | LCK | 1.64166420 |
27 | BTK | 1.59833440 |
28 | HCK | 1.57918115 |
29 | MST4 | 1.57565072 |
30 | MAP3K13 | 1.38592262 |
31 | TNIK | 1.36732880 |
32 | GRK6 | 1.32958287 |
33 | MAP3K11 | 1.24845430 |
34 | MARK3 | 1.22189955 |
35 | MAP3K3 | 1.22159919 |
36 | LYN | 1.22109159 |
37 | PRKCQ | 1.20656836 |
38 | SIK2 | 1.15006252 |
39 | MAP3K1 | 1.08175185 |
40 | PKN1 | 1.04394281 |
41 | TGFBR2 | 1.03060443 |
42 | MAPK12 | 1.00248096 |
43 | KSR2 | 0.99303721 |
44 | CAMKK1 | 0.98868659 |
45 | PRPF4B | 0.98761031 |
46 | TEC | 0.98550294 |
47 | SMG1 | 0.97745113 |
48 | YES1 | 0.96120193 |
49 | CDK12 | 0.92359088 |
50 | OXSR1 | 0.92142618 |
51 | PRKCH | 0.90501612 |
52 | JAK2 | 0.85284308 |
53 | PIK3CG | 0.84913171 |
54 | FGFR4 | 0.84354902 |
55 | CHUK | 0.82799115 |
56 | CAMKK2 | 0.82789558 |
57 | TYRO3 | 0.80309702 |
58 | ALK | 0.78309948 |
59 | ICK | 0.78259577 |
60 | IRAK1 | 0.76673536 |
61 | IRAK2 | 0.74500174 |
62 | MAP3K10 | 0.74107816 |
63 | SGK3 | 0.73423745 |
64 | MAP3K7 | 0.73149380 |
65 | CDK19 | 0.72509142 |
66 | PIM1 | 0.71920074 |
67 | SGK2 | 0.71553157 |
68 | FYN | 0.70622715 |
69 | FGFR3 | 0.69977610 |
70 | LRRK2 | 0.69945798 |
71 | TESK2 | 0.68266231 |
72 | NLK | 0.66035092 |
73 | TAOK2 | 0.64667415 |
74 | TAOK3 | 0.64354284 |
75 | STK11 | 0.63878984 |
76 | PDK1 | 0.60835014 |
77 | CAMK1G | 0.60718653 |
78 | SIK3 | 0.59285090 |
79 | PDGFRB | 0.58811815 |
80 | ERN1 | 0.57367948 |
81 | TNK2 | 0.56176099 |
82 | STK4 | 0.55971320 |
83 | BMPR2 | 0.54355356 |
84 | HIPK2 | 0.54130996 |
85 | PTK2B | 0.53605945 |
86 | DMPK | 0.52966512 |
87 | EEF2K | 0.52817538 |
88 | ABL1 | 0.52283397 |
89 | WNK1 | 0.51991645 |
90 | MATK | 0.51732547 |
91 | TRIB3 | 0.51641588 |
92 | EGFR | 0.50677213 |
93 | RET | 0.50013991 |
94 | PRKD2 | 0.49166897 |
95 | STK38 | 0.47048782 |
96 | BRD4 | 0.46999286 |
97 | MAP2K3 | 0.46873198 |
98 | DAPK2 | 0.45939758 |
99 | CDC42BPA | 0.44935046 |
100 | CSNK1A1L | 0.44836677 |
101 | SIK1 | 0.44539072 |
102 | SGK223 | 0.44488511 |
103 | SGK494 | 0.44488511 |
104 | PBK | 0.44360746 |
105 | PASK | 0.44360692 |
106 | RPS6KA4 | 0.43515200 |
107 | CAMK1D | 0.41742691 |
108 | ROCK2 | 0.40843077 |
109 | GRK7 | 0.40600629 |
110 | INSR | 0.40525498 |
111 | BMX | 0.40175497 |
112 | CDK4 | 0.39690968 |
113 | CAMK4 | 0.39118527 |
114 | PRKCD | 0.38506947 |
115 | MARK2 | 0.37546634 |
116 | MAP3K2 | 0.37500072 |
117 | PDPK1 | 0.37438546 |
118 | TRPM7 | 0.36985259 |
119 | MAPK11 | 0.36548790 |
120 | MAP3K5 | 0.36206390 |
121 | CSNK1G3 | 0.35890039 |
122 | MAPKAPK2 | 0.34952818 |
123 | GRK5 | 0.34833795 |
124 | UHMK1 | 0.33884858 |
125 | TAOK1 | 0.33572110 |
126 | MAPK7 | 0.33231650 |
127 | MELK | 0.30580090 |
128 | RAF1 | 0.30140275 |
129 | DYRK1B | 0.30027473 |
130 | PTK6 | 0.29909093 |
131 | EPHA3 | 0.27490117 |
132 | NME2 | 0.26340191 |
133 | GSK3A | 0.23402514 |
134 | RPS6KA5 | 0.23025140 |
135 | SRC | 0.21727191 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01043199 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.63402669 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63046091 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44270051 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40715099 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39234640 |
7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.28761015 |
8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.20211849 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.19722496 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17296606 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16465918 |
12 | Measles_Homo sapiens_hsa05162 | 2.03877162 |
13 | Asthma_Homo sapiens_hsa05310 | 1.96790016 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94850603 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94297589 |
16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81475045 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80028076 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77981303 |
19 | Malaria_Homo sapiens_hsa05144 | 1.73356589 |
20 | Lysosome_Homo sapiens_hsa04142 | 1.69941692 |
21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66538189 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.63484872 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57768825 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57438555 |
25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55898621 |
26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.53225564 |
27 | Shigellosis_Homo sapiens_hsa05131 | 1.52178479 |
28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50561043 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.49403880 |
30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45517880 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43974232 |
32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43582646 |
33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40058705 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39731397 |
35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36765444 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31749584 |
37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.26087827 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.25515973 |
39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24751795 |
40 | Salmonella infection_Homo sapiens_hsa05132 | 1.24694600 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.23760823 |
42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22752784 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.16820660 |
44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16291474 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.10354499 |
46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09171984 |
47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06327523 |
48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05715166 |
49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05557640 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 1.04288654 |
51 | Phagosome_Homo sapiens_hsa04145 | 1.01984340 |
52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00643895 |
53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00243410 |
54 | Platelet activation_Homo sapiens_hsa04611 | 0.97044571 |
55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96495241 |
56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94307992 |
57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94207072 |
58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92459558 |
59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91948620 |
60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91552477 |
61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89300422 |
62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87901033 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87796261 |
64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87236865 |
65 | Endocytosis_Homo sapiens_hsa04144 | 0.84635259 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80483543 |
67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79139339 |
68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77755477 |
69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77492184 |
70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74131110 |
71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74026680 |
72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72227420 |
73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71131529 |
74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69160193 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67001693 |
76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66293084 |
77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66000266 |
78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64733994 |
79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62120754 |
80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60886744 |
81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56418557 |
82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55801607 |
83 | Glioma_Homo sapiens_hsa05214 | 0.54203555 |
84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54100879 |
85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53805213 |
86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52530899 |
87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51728549 |
88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51473558 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50782742 |
90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50684364 |
91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50037713 |
92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49835420 |
93 | Insulin resistance_Homo sapiens_hsa04931 | 0.49228653 |
94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48760547 |
95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47992569 |
96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47309344 |
97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46889130 |
98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46589273 |
99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46584205 |
100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46349695 |
101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45436060 |
102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44299134 |
103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44213999 |
104 | Amoebiasis_Homo sapiens_hsa05146 | 0.42037228 |
105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41670861 |
106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40570136 |
107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39488077 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39252110 |
109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37902104 |
110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35878278 |
111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35396868 |
112 | Prostate cancer_Homo sapiens_hsa05215 | 0.34951183 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31605358 |
114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29518601 |
115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29371790 |
116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28889067 |
117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28774832 |
118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28653269 |